XML 65 R35.htm IDEA: XBRL DOCUMENT v3.21.1
Share Capital and Other Equity Instruments - Schedule of Stock Options (Details) - USD ($)
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Share Capital And Other Equity Instruments - Schedule Of Stock Options    
Number of Shares, Outstanding at beginning of the year 797,373 689,832
Number of Shares, Granted 378,800 448,713
Number of Shares, Expired, forfeited, or cancelled (246,408) (341,172)
Number of Shares, Outstanding at end of the year 929,765 797,373
Number of Shares, Exercisable at December 31, 2020 929,765  
Weighted Average Exercise Price, Outstanding at beginning of the year $ 1.99 $ 1.94
Weighted Average Exercise Price, Granted 0.94 1.99
Weighted Average Exercise Price, Expired, forfeited, or cancelled 1.94 1.99
Weighted Average Exercise Price, Outstanding at end of the year 1.53 $ 1.99
Weighted Average Exercise Price, Exercisable at December 31, 2020 $ 1.53  
Weighted Average Grant Date Fair Value, Outstanding at beginning of the year 0.72 1.94
Weighted Average Grant Date Fair Value, Granted $ 5.22 $ 1.49
Weighted Average Grant Date Fair Value, Expired, forfeited, or cancelled $ 0.88 $ 0.36
Weighted Average Grant Date Fair Value, Outstanding at end of the year 2.50 0.72
Weighted Average Grant Date Fair Value, Exercisable at December 31, 2020 $ 2.50  
Weighted Average Remaining Contractual Term (years), Outstanding at December 31, 2020 6 years 1 month 6 days  
Weighted Average Remaining Contractual Term (years), Exercisable at December 31, 2020 6 years 1 month 6 days  
Aggregate Intrinsic Value, Outstanding at December 31, 2020 $ 2,537,245  
Aggregate Intrinsic Value, Exercisable at December 31, 2020 $ 2,537,245